BLTE Belite Bio, Inc - American Depositary Shares
$141.06
Price · May 20, 2026
52W Range
$56–$192
62% of range
Analyst Rating
BUY
14 analysts
Price Target
$212
+50% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
BLTE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$141.06
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$56 – $192
BLTE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BLTE
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BLTE
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BLTE
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BLTE
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BLTE
Peer Median
BLTE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
14 analysts
- Strong Buy 4 28.6%
- Buy 9 64.3%
- Hold 1 7.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
8 analysts · 2026-05-16
Median
$200.50
Mean
$211.50
← Below all targets
$141.06
Low
$185.00
High
$266.00
Median target
$200.50
+42.1%
Mean target
$211.50
+49.9%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.11%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2025 | $-0.70 | $-0.56 | -0.14% |
| Sept. 30, 2025 | $-0.65 | $-0.50 | -0.15% |
| June 30, 2025 | $-0.50 | $-0.43 | -0.07% |
| March 31, 2025 | $-0.45 | $-0.38 | -0.07% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BLTE | — | — | — | — | — | — |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | — |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | — |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | — |
| INDV | — | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | — |
| MANE | — | — | — | — | 82.6% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| CRNX | $4.45B | -9.4 | 640.7% | -6046.2% | -43.0% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.